Stocktoria
Ambiq Micro, Inc. AMBQ
Ambiq Micro, Inc. financials (annual)
Bars are annual figures from 2024 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | $72.5M | $76.1M |
| Gross profit | $32.1M | $24.3M |
| R&D expense | $38.5M | $37.2M |
| SG&A expense | $33.2M | $27.7M |
| Operating income | -$39.5M | -$40.6M |
| Income tax | $40,000 | $28,000 |
| Net income | -$36.5M | -$39.7M |
| EPS (diluted) | $-4.57 | $-113.50 |
| Operating cash flow | -$19.7M | -$21.4M |
| Cash & equivalents | $140.3M | $61.0M |
| Inventory | $16.9M | $15.0M |
| Total assets | $184.7M | $104.3M |
| Total liabilities | $22.2M | $18.5M |
| Shareholders' equity | $162.5M | -$292.4M |
Growth · year-over-year · Revenue CAGR -4.7%
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue growth | -4.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.